Related Experiment Video
Updated: May 13, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
Shou-Mei Yang1, Cheng Huang, Xiao-Feng Li
1School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China.
Abstract:
Resistance to chemotherapy is a major obstacle for the effective treatment of cancers. The mechanism of chemo-resistance is still poorly understood, however, mounting evidence supports a role for microRNAs (miRNAs) in modulating key cellular pathways mediating response to chemotherapy. microRNA-21 (miR-21) has been implicated in many cancers and contributed to chemo-resistance, but its role in gastric cancer drug resistance still remains unexplored. The aim of this study was to investigate whether miR-21 mediated resistance of the gastric cancer cell line SGC7901 to the chemotherapeutic agent cisplatin (DDP). Our study found that the expression of miR-21 upregulated in the cisplatin resistant cell line SGC7901/DDP compared to its parental line SGC7901. Moreover, over-expression of miR-21 significantly decreased antiproliferative effects and apoptosis induced by cisplatin, while knockdown of miR-21 dramatically increased antiproliferative effects and apoptosis induction by cisplatin. In addition, miR-21 induced cell survival and cisplatin resistance through downregulating the expression of phosphatase and tension homolog deleted on chromosome 10 (PTEN) and activation of Akt pathway. Inhibition of Akt using PI3K inhibitor LY 294002 could abrogate miR-21 induced cell survival. These results suggest that miR-21 may provide a novel mechanism for understanding cisplatin resistance in gastric cancer by modulating PTEN/PI3K/Akt pathway.
Insights
MicroRNA-21 (miR-21) promotes cisplatin resistance in gastric cancer by downregulating PTEN and activating the Akt pathway. Inhibiting miR-21 can enhance chemotherapy effectiveness, offering a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chemotherapy resistance is a significant challenge in cancer treatment.
- MicroRNAs (miRNAs) play a role in drug resistance pathways.
- The function of microRNA-21 (miR-21) in gastric cancer drug resistance is largely unknown.
Purpose of the Study:
- To investigate the role of miR-21 in mediating resistance to cisplatin (DDP) in gastric cancer cells.
- To explore the underlying molecular mechanisms of miR-21-induced chemoresistance.
Main Methods:
- Comparison of miR-21 expression in cisplatin-sensitive (SGC7901) and resistant (SGC7901/DDP) gastric cancer cell lines.
- Manipulation of miR-21 levels (overexpression and knockdown) to assess effects on cisplatin sensitivity.
- Analysis of PTEN expression and Akt pathway activation.
- Inhibition of the Akt pathway using LY 294002.
Main Results:
- miR-21 expression was significantly upregulated in cisplatin-resistant gastric cancer cells.
- Overexpression of miR-21 reduced cisplatin-induced apoptosis and proliferation inhibition.
- Knockdown of miR-21 increased sensitivity to cisplatin.
- miR-21 conferred resistance by downregulating PTEN and activating the Akt pathway.
- Inhibition of Akt signaling abrogated miR-21-mediated cell survival.
Conclusions:
- miR-21 plays a crucial role in conferring cisplatin resistance in gastric cancer.
- The miR-21/PTEN/PI3K/Akt pathway is a key mechanism underlying chemoresistance.
- Targeting miR-21 may represent a novel therapeutic strategy for overcoming cisplatin resistance in gastric cancer.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
